Get Fit Bharat

Tag: Program

HomeProgram

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT …

Ayanika, a brand renowned for its exquisite, concept-driven lab grown diamond jewelry collections, is proud to announce the grand opening of its flagship store at Laxmi Industrial Estate, Andheri. With a vision to redefine luxury, Ayanika blends artistry, craftsmanship, and personalization to offer customers a truly unique jewelry experience.   …

Sandbäckens, part of the Nimlas Group, starts its second electricity company - Sandbäckens El & Automation in Gothenburg. The investment is part of Sandbäckens 5-50-500 strategy: 5 billion in turnover, 50 new companies, 500 million in profit and we plan to grow strongly in all disciplines. The goal is …

Nordea Bank Abp Stock exchange release – Total number of voting rights and capital 21 January 2025 at 9.15 EET Nordea has today cancelled 4,841,641 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. …

  Hyderabad, Telangana, India:  The QE Conclave 2024, held recently at the Trident Hotel in Hyderabad, marked a significant milestone in its annual journey of advancing the field of Quality Engineering (QE). The premier QE community event attracted more than 600 professionals from over 300 leading global and national organizations, making it …

Halton, a global technology leader in demanding indoor air solutions commits to set a near-term science-based target as well as a net zero target aligned with the requirements of the Science-Based Targets initiative (SBTi). Halton’s commitment includes reducing its Scope 1 and Scope 2 emissions, and engaging with its suppliers to …

Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, announces that the first two patients have been treated in the company’s Phase I/II clinical trial. The trial investigates the safety and tolerability of a new, tailored treatment for advanced colorectal cancer, a disease with significant medical needs …